These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8824468)

  • 61. Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection.
    Malassagne B; Regimbeau JM; Taboit F; Troalen F; Chéreau C; Moiré N; Attal J; Batteux F; Conti F; Calmus Y; Houssin D; Boulard C; Houdebine LM; Weill B
    Xenotransplantation; 2003 May; 10(3):267-77. PubMed ID: 12694547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complement activation, its consequences, and blockade by gene transfer.
    Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ
    World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man.
    White DJ; Yannoutsos N
    Res Immunol; 1996 Feb; 147(2):88-94. PubMed ID: 8792466
    [No Abstract]   [Full Text] [Related]  

  • 64. Life supporting function for over one month of a transgenic porcine heart in a baboon.
    Vial CM; Ostlie DJ; Bhatti FN; Cozzi E; Goddard M; Chavez GP; Wallwork J; White DJ; Dunning JJ
    J Heart Lung Transplant; 2000 Feb; 19(2):224-9. PubMed ID: 10703701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutralization of anti-alphaGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons.
    Manez R; Crespo F; Gonzalez E; Centeno A; Juffe A; Arnal F; Cozzi E; White DJ; Duthaler R; Kinzy W; Oehrlein R; Katopodis A
    Transplant Proc; 2000 Aug; 32(5):888-9. PubMed ID: 10936260
    [No Abstract]   [Full Text] [Related]  

  • 66. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
    Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
    Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.
    Dalmasso AP; Vercellotti GM; Platt JL; Bach FH
    Transplantation; 1991 Sep; 52(3):530-3. PubMed ID: 1716798
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Absence of hyperacute rejection and preservation of function in HDAF transgenic pig kidneys exposed to prolonged cold ischaemia.
    Masroor S; Cozzi E; Soin B; Vial C; Chavez G; Smith KG; Bradley JR; White DJ; Friend PJ
    Transplant Proc; 2000 Aug; 32(5):965-6. PubMed ID: 10936300
    [No Abstract]   [Full Text] [Related]  

  • 71. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2.
    Ross JR; Kirk AD; Ibrahim SE; Howell DN; Baldwin WM; Sanfilippo FP
    Transplantation; 1993 May; 55(5):1144-50. PubMed ID: 8497896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention of hyperacute xenograft rejection through direct thrombin inhibition with hirudin.
    Brenner P; Keller M; Beiras-Fernandez A; Uchita S; Kur F; Thein E; Wimmer C; Hammer C; Schmoeckel M; Reichart B
    Ann Transplant; 2010; 15(4):30-7. PubMed ID: 21183873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
    Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
    Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The generation of transgenic pigs as potential organ donors for humans.
    Cozzi E; White DJ
    Nat Med; 1995 Sep; 1(9):964-6. PubMed ID: 7585226
    [No Abstract]   [Full Text] [Related]  

  • 75. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
    Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.
    Fecke W; Long J; Richards A; Harrison R
    Xenotransplantation; 2002 Mar; 9(2):97-105. PubMed ID: 11897002
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
    Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses.
    Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF
    Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A soluble chimeric inhibitor of C3 and C5 convertases, complement activation blocker-2, prolongs graft survival in pig-to-rhesus monkey heart transplantation.
    Salerno CT; Kulick DM; Yeh CG; Guzman-Paz M; Higgins PJ; Benson BA; Park SJ; Shumway SJ; Bolman RM; Dalmasso AP
    Xenotransplantation; 2002 Mar; 9(2):125-34. PubMed ID: 11897005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.